What is Arvinas's stock-based comp?

Arvinas (ARVN) reported stock-based comp of $12.1M in Q1 2026.

How has Arvinas's stock-based comp changed year-over-year?

Arvinas's stock-based comp decreased by 19.3% year-over-year, from $15M to $12.1M.

What is the long-term trend for Arvinas's stock-based comp?

Over 4 years (2021 to 2025), Arvinas's stock-based comp has grown at a -6.3% compound annual growth rate (CAGR), from $57.1M to $44M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Arvinas ARVN Stock-Based Comp

Stock-Based Comp at other companies

Nurix Therapeutics, Inc.NRIX

$9.4M+7.8%

Kymera TherapeuticsKYMR

$16.01M+12.5%

Monte Rosa Therapeutics, Inc.GLUE

$5.95M+12.3%

Relmada Therapeutics, Inc.RLMD

$956.19K-73.2%

Nuvectis Pharma, Inc.NVCT

$1.85M+35.2%

ArriVent BioPharma, Inc.AVBP

$5.49M+142%

Other financials

Income statement

See full

Revenue$15.6M-91.7%

Operating income-$63.8M-189%

Net income-$57.6M-169%

EPS (diluted)-$0.90-179%

Balance sheet

See full

Cash & equivalents$87.3M+7.8%

Total debt$8.6M-19.6%

Total equity$386.8M-41.4%

Total assets$647.5M-35.3%

Cash flow

See full

Operating cash flow-$69.2M+22.2%

CapEx$1.3M+225%

Free cash flow-$70.5M+21.1%

Valuation

See full

Market cap$518.11M-4.6%

Enterprise value$439.41M-7.1%

P/S5.8×+4.5×

Profitability

See full

Operating margin-283.8%-310pp

Net margin-247.5%-260pp

FCF margin-287.4%—

Returns & leverage

See full

Return on equity-42.3%-53.5pp

Debt / equity0×0.0×

Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arvinas's stock-based comp?: Arvinas (ARVN) reported stock-based comp of $12.1M in Q1 2026.
How has Arvinas's stock-based comp changed year-over-year?: Arvinas's stock-based comp decreased by 19.3% year-over-year, from $15M to $12.1M.
What is the long-term trend for Arvinas's stock-based comp?: Over 4 years (2021 to 2025), Arvinas's stock-based comp has grown at a -6.3% compound annual growth rate (CAGR), from $57.1M to $44M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.